Silencing of autoreactive B cells by anergy: a fresh perspective
- PMID: 16616480
- DOI: 10.1016/j.coi.2006.03.015
Silencing of autoreactive B cells by anergy: a fresh perspective
Abstract
B-cell antigen receptor (BCR) signals are crucial for initiation of humoral immune responses and must be actively modulated and/or terminated in preparation for receipt of subsequent cues for progression. BCR signaling is also actively inhibited in autoreactive cells in which unresponsiveness is maintained by anergy. This serves to prevent cell activation and autoimmunity. Importantly, the feedback mechanisms that modulate and/or terminate signaling during normal antigen-induced B-cell activation appear to also be involved in maintaining B-cell anergy. In fact, it is suggested that anergy reflects nothing more than the normal inability of cells to respond to antigen following preceding stimulation of normal inhibitory feedback mechanisms. Thus, the time-honored two-signal hypothesis is almost certainly correct, with second signals being required to release the cell from inhibitory BCR-specific and trans-active feedback regulation.
Similar articles
-
Maintenance of B cell anergy requires constant antigen receptor occupancy and signaling.Nat Immunol. 2005 Nov;6(11):1160-7. doi: 10.1038/ni1256. Epub 2005 Oct 2. Nat Immunol. 2005. PMID: 16200069
-
Identification of anergic B cells within a wild-type repertoire.Immunity. 2006 Dec;25(6):953-62. doi: 10.1016/j.immuni.2006.10.017. Immunity. 2006. PMID: 17174121
-
Resistance to CpG DNA-induced autoimmunity through tolerogenic B cell antigen receptor ERK signaling.Nat Immunol. 2003 Jun;4(6):594-600. doi: 10.1038/ni924. Epub 2003 May 11. Nat Immunol. 2003. PMID: 12740574
-
Multiple paths to loss of anergy and gain of autoimmunity.Autoimmunity. 2007 Sep;40(6):418-24. doi: 10.1080/08916930701464723. Autoimmunity. 2007. PMID: 17729035 Review.
-
Activation of self-reactive B cells and autoimmune diseases.Rev Immunogenet. 2000;2(1):38-51. Rev Immunogenet. 2000. PMID: 11324692 Review.
Cited by
-
B cells and type 1 diabetes ...in mice and men.Immunol Lett. 2014 Aug;160(2):128-32. doi: 10.1016/j.imlet.2014.01.010. Epub 2014 Jan 25. Immunol Lett. 2014. PMID: 24472603 Free PMC article. Review.
-
Review of Mouse Models of Graves' Disease and Orbitopathy-Novel Treatment by Induction of Tolerance.Clin Rev Allergy Immunol. 2017 Apr;52(2):182-193. doi: 10.1007/s12016-016-8562-7. Clin Rev Allergy Immunol. 2017. PMID: 27368808 Free PMC article. Review.
-
Augmented B lymphocyte response to antigen in the absence of antigen-induced B lymphocyte signaling in an IgG-transgenic mouse line.PLoS One. 2010 Jan 21;5(1):e8815. doi: 10.1371/journal.pone.0008815. PLoS One. 2010. PMID: 20098688 Free PMC article.
-
Ikaros in B cell development and function.World J Biol Chem. 2011 Jun 26;2(6):132-9. doi: 10.4331/wjbc.v2.i6.132. World J Biol Chem. 2011. PMID: 21765979 Free PMC article.
-
Islet-antigen reactive B cells display a unique phenotype and BCR repertoire in autoantibody positive and recent-onset type 1 diabetes patients.bioRxiv [Preprint]. 2024 Jun 25:2024.06.20.599914. doi: 10.1101/2024.06.20.599914. bioRxiv. 2024. PMID: 38979376 Free PMC article. Preprint.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources